Skip to main content

Table 2 Ophthalmic information of involved studies

From: Surgery outcomes of lamellar macular eyes with or without lamellar hole-associated epiretinal proliferation: a meta-analysis

Author

Parolini et al.

Lai et al.

Ko et al.

Choi et al.

Ho et al.

Takahashi et al.

Figueroa et al.

Morescalchi et al.

BCVA (pre-operation)

 Without LHEP

0.40 ± 0.20

0.72 ± 0.32

0.30 ± 0.26

0.48 ± 0.18

0.38 ± 0.19

 With LHEP

0.40 ± 0.20

0.79 ± 0.37

0.38 ± 0.38

0.50 ± 0.25

0.37 ± 0.27

0.31 ± 0.25

0.56 ± 0.19

0.44 ± 0.16

BCVA (post-operation)

 Without LHEP

0.20 ± 0.30

0.43 ± 0.44

0.10 ± 0.10

0.16 ± 0.16

0.18 ± 0.17

 With LHEP

0.20 ± 0.20

0.45 ± 0.39

0.33 ± 0.40

0.40 ± 0.29

0.17 ± 0.21

0.10 ± 0.25

0.39 ± 0.28

0.17 ± 0.13

EZD (pre-operation)

 Without LHEP

9 (24)

0 (42)

3 (11)

11 (77)

 With LHEP

13 (19)

2 (10)

10 (11)

10 (33)

15 (34)

13 (26)

EZD (post-operation)

 Without LHEP

8 (24)

2 (42)

2 (11)

6 (77)

 With LHEP

7 (19)

2 (10)

8 (11)

4 (33)

8 (34)

12 (26)

CRT (pre-operation) (μm)

 Without LHEP

166.7 ± 62.0

 With LHEP

96.3 ± 33.2

123.2 ± 42.6

146 ± 34

CRT (post-operation) (μm)

 Without LHEP

230.6 ± 103.3

 With LHEP

205.6 ± 112.9

191.2 ± 45.3

272 ± 24

  1. Abbreviations: BCVA Best corrected visual acuity, CRT Central Retinal Thickness, EZD Ellipsoid zone destruction, LHEP Lamellar hole-associated epiretinal proliferation